VC firms
HBM Holdings is a privately held, global conglomerate focused on strategically acquiring and partnering with middle-market industrial companies.
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 23, 2026 | Nona Biosciences Enters Research Collaboration with the Medical University of Vienna to Advance Fully Human Antibody Development for Infectious Diseases | Partnership grants Ignaz Semmelweis Institute access to Nona's H2L2 Harbour Mice® transgenic mouse technology platform for translational antibody research CAMBRIDGE, Mass., July 23, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), ... |
| Jul 2, 2026 | Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-Class Single-Domain Antibody-Based BBB-Crossing Technology for CNS Diseases | CAMBRIDGE, Mass., July 2, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, today announced a strategic collaborat... |
Reviews 0
FAQ about HBM Holdings
What has the press written about HBM Holdings?
Parsers VC has collected 3 articles mentioning HBM Holdings, among them “Nona Biosciences Enters Research Collaboration with the Medical University of Vienna to Advance Fully Human Antibody Development for Infectious Diseases” (Jul 23, 2026) and “Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-Class Single-Domain Antibody-Based BBB-Crossing Technology for CNS Diseases” (Jul 2, 2026).
Is HBM Holdings still active?
Yes, HBM Holdings is active; its latest activity on Parsers VC dates from Sep 16, 2026.